论文部分内容阅读
目的:分析研究埃索美拉唑与奥美拉唑治疗胃溃疡的临床应用价值。方法:选取2013年2月-2015年5月在我院接收的患有胃溃疡的患者一共有114例,随机分为研究组、对照组,对照组对病人采取奥美拉唑进行治疗,研究组对病人采取埃索美拉唑进行治疗,对两组病人的临床效果以及不良反应等给予对比分析。结果:临床治疗之前,两组病人的临床症状积分差异无统计学意义(P>0.05),临床治疗以后,研究组病人的临床症状积分明显低于对照组(P<0.05);临床治疗以后,研究组患者的不良反应发生率明显低于对照组(P<0.05);临床治疗以后,研究组的临床治疗总体有效率明显高于对照组(P<0.05);临床治疗以后,研究组的Hp根除率明显高于对照组(P<0.05)。结论:对胃溃疡采取埃索美拉唑进行治疗,可以取得令人满意的治疗效果,并且不良反应较少,具有临床推广价值。
Objective: To analyze the clinical value of esomeprazole and omeprazole in the treatment of gastric ulcer. Methods: A total of 114 patients with gastric ulcer received in our hospital from February 2013 to May 2015 were randomly divided into study group, control group and control group. The patients were treated with omeprazole, Group of patients taking esomeprazole for treatment, the clinical effect of two groups of patients and adverse reactions were given comparative analysis. Results: Before clinical treatment, there was no significant difference in clinical symptom scores between the two groups (P> 0.05). After clinical treatment, clinical symptom scores in study group were significantly lower than those in control group (P <0.05). After clinical treatment, The incidence of adverse reactions in study group was significantly lower than that in control group (P <0.05). After clinical treatment, the overall effective rate of clinical treatment in study group was significantly higher than that in control group (P <0.05). After treatment, Hp Eradication rate was significantly higher than the control group (P <0.05). Conclusion: The treatment of gastric ulcer with esomeprazole can achieve satisfactory therapeutic effect, and less adverse reactions, with clinical promotion value.